Evidence map›Paper›PMID 37828599›Full record

ArticleJournal of nanobiotechnology2023

Eobania vermiculata whole-body muscle extract-loaded chitosan nanoparticles enhanced skin regeneration and decreased pro-inflammatory cytokines in vivo.

Alyaa Farid, Adham Ooda, Ahmed Nabil, Areej Nasser, Esraa Ahmed, Fatma Ali, Fatma Mohamed, Habiba Farid, Mai Badran, Mariam Ahmed and 6 more

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Journal of nanobiotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Impacts ofToxicology research · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Alyaa FaridBiotechnology Department, Faculty of Science, Cairo University, Giza, Egypt. alyaafarid@cu.edu.eg.ORCID http://orcid.org/0000-0003-0706-347X
Adham OodaBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Ahmed NabilBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Areej NasserBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Esraa AhmedBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Fatma AliBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Fatma MohamedBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Habiba FaridBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Mai BadranBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Mariam AhmedBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Mariam IbrahimBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Mariam RasmyBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Martina SaleebBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Vereena RiadBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Yousr IbrahimBiotechnology/Biomolecular Chemistry Program, Faculty of Science, Cairo University, Giza, Egypt.
Neveen MadboulyZoology Department, Faculty of Science, Cairo University, Giza, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUsually, wounds recover in four to six weeks. Wounds that take longer time than this to heal are referred to as chronic wounds. Impaired healing can be caused by several circumstances like hypoxia, microbial colonization, deficiency of blood flow, reperfusion damage, abnormal cellular reaction and deficiencies in collagen production. Treatment of wounds can be enhanced through systemic injection of the antibacterial drugs and/or other topical applications of medications. However, there are a number of disadvantages to these techniques, including the limited or insufficient medication penetration into the underlying skin tissue and the development of bacterial resistance with repeated antibiotic treatment. One of the more recent treatment options may involve using nanotherapeutics in combination with naturally occurring biological components, such as snail extracts (SE). In this investigation, chitosan nanoparticles (CS NPs) were loaded with an Eobania vermiculata whole-body muscle extract. The safety of the synthesized NPs was investigated in vitro to determine if these NPs might be utilized to treat full-skin induced wounds in vivo.

resultsSEM and TEM images showed uniformly distributed, spherical, smooth prepared CS NPs and snail extract-loaded chitosan nanoparticles (SE-CS NPs) with size ranges of 76-81 and 91-95 nm, respectively. The zeta potential of the synthesized SE-CS NPs was - 24.5 mV, while that of the CS NPs was 25 mV. SE-CS NPs showed a remarkable, in vitro, antioxidant, anti-inflammatory and antimicrobial activities. Successfully, SE-CS NPs (50 mg/kg) reduced the oxidative stress marker (malondialdehyde), reduced inflammation, increased the levels of the antioxidant enzymes (superoxide dismutase and glutathione), and assisted the healing of induced wounds. SE-CS NPs (50 mg/kg) can be recommended to treat induced wounds safely. SE was composed of a collection of several wound healing bioactive components [fatty acids, amino acids, minerals and vitamins) that were loaded on CS NPs.

conclusionsThe nanostructure enabled bioactive SE components to pass through cell membranes and exhibit their antioxidant and anti-inflammatory actions, accelerating the healing process of wounds. Finally, it is advised to treat rats' wounds with SE-CS NPs.

Indexed as

ChitosanNanoparticlesAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsCytokinesMusclesRatsWound HealingAnti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsChitosanCytokinesChitosanCytokinesEobania vermiculataNanoparticlesWound

Identifiers

PMID37828599
PMCPMC10571447
OpenAlexW4387597807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.